Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas.
Carlander AF, Bendtsen SK, Rasmussen JH, Jakobsen KK, Garset-Zamani M, Grønhøj C, Friborg J, Hutcheson K, Johnson FM, Fuller CD, Moreno AC, Babarinde T, Gross ND, Myers JN, von Buchwald C. Carlander AF, et al. Among authors: fuller cd. Eur J Cancer. 2024 May;202:113983. doi: 10.1016/j.ejca.2024.113983. Epub 2024 Mar 2. Eur J Cancer. 2024. PMID: 38452723 Free PMC article.
Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
MD Anderson Head and Neck Cancer Symptom Working Group. MD Anderson Head and Neck Cancer Symptom Working Group. Radiother Oncol. 2016 Feb;118(2):304-14. doi: 10.1016/j.radonc.2016.01.019. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897515 Free PMC article.
A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
Joint Head and Neck Radiotherapy-MRI Development Cooperative. Joint Head and Neck Radiotherapy-MRI Development Cooperative. Radiother Oncol. 2019 Jan;130:46-55. doi: 10.1016/j.radonc.2018.08.010. Epub 2018 Sep 8. Radiother Oncol. 2019. PMID: 30206020 Free PMC article. Clinical Trial.
Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation.
Wang JH, Salama V, McCoy L, Dede C, Ajayi T, Moreno A, Mohamed ASR, Hutcheson KA, Fuller CD, van Dijk LV; MD Anderson Head and Neck Symptom Working Group. Wang JH, et al. Among authors: fuller cd. Radiother Oncol. 2023 Mar;180:109465. doi: 10.1016/j.radonc.2023.109465. Epub 2023 Jan 11. Radiother Oncol. 2023. PMID: 36640945 Free PMC article.
Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool.
Wentzel A, Mohamed ASR, Naser MA, van Dijk LV, Hutcheson K, Moreno AM, Fuller CD, Canahuate G, Marai GE. Wentzel A, et al. Among authors: fuller cd. Front Oncol. 2023 Aug 8;13:1210087. doi: 10.3389/fonc.2023.1210087. eCollection 2023. Front Oncol. 2023. PMID: 37614495 Free PMC article.
Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based Model.
Watson EE, Hueniken K, Lee J, Huang SH, Maghrabi A AE, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CM, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA. Watson EE, et al. Among authors: fuller cd. medRxiv [Preprint]. 2023 Sep 13:2023.09.12.23295454. doi: 10.1101/2023.09.12.23295454. medRxiv. 2023. Update in: J Clin Oncol. 2024 Jun 1;42(16):1922-1933. doi: 10.1200/JCO.23.01951 PMID: 37745576 Free PMC article. Updated. Preprint.
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB. Sherry AD, et al. Among authors: fuller cd. Eur J Cancer. 2023 Nov;194:113357. doi: 10.1016/j.ejca.2023.113357. Epub 2023 Sep 22. Eur J Cancer. 2023. PMID: 37827064 Free PMC article.
537 results